Senior Director, Clinical Affairs
Amber Van Laar, MD
Dr. Van Laar obtained her MD from the University of Pittsburgh School of Medicine, with subsequent residency training in Neurology and clinical-research fellowship training in Movement Disorders at the University of Pittsburgh Medical Center. Upon completion of training, she continued her academic research in the Pittsburgh Institute for Neurodegenerative Diseases as an Assistant Professor in Neurology. In her clinical practice, Dr. Van Laar focused on neuromodulatory aspects of Movement Disorders providing specialty care for patients with deep brain stimulation (DBS) implanted for Parkinson’s disease, dystonia, and tremors. She has also contributed to the Parkinson’s disease community through local support groups and a leadership role on the board of directors for the Parkinson’s Foundation of Western PA. Prior to her medical training, Dr. Van Laar had been involved in preclinical gene therapy approaches in parkinsonian rodent models. After her clinical fellowship, she continued gene therapy focused research for which she received the 3-year Clinician-Scientist Development Award from the Parkinson’s Foundation and the American Academy of Neurology to investigate the therapeutic potential of a viral-mediated gene therapy in parkinsonian models. To further enhance her clinical research skills, Dr. Van Laar completed a certificate from the Institute of Clinical Research Education from the University of Pittsburgh. As a physician scientist, Dr. Van Laar has also participated in clinical trials for neurodegenerative diseases, including work with Voyager Therapeutics, Inc. on gene therapy approaches for Parkinson’s disease. She has since joined Brain Neurotherapy Bio, Inc. bringing a unique amalgamation of preclinical, clinical, and industry experience to her role in Clinical Affairs.